LSNE of Bedford announces facilities expansion, additional positions to accommodate growth
The company will add approximately 20 full-time positions to its analytical and operations workforce
Lyophilization Services of New England, or LSNE, a Bedford-based contract manufacturer that serves pharmaceutical, biotech and medical device clients, announced today it will expand its quality control laboratory in Bedford and provide new employment opportunities for its analytical and operations workforce.
This expansion is part of LSNE’s strategic growth plan to enhance its operations and capacity to better serve its customers.
LSNE’s expansion plan includes 38,000 square feet of new quality control laboratory space and newly renovated centralized warehouse, which will offer longer term product storage for clients. The laboratory and warehouse are scheduled to be validated and operational during the second quarter of 2018. Additionally, in conjunction with this expansion, LSNE will add approximately 20 new full-time positions. As construction is performed, LSNE’s current QC lab will remain fully operational to avoid any interruption to ongoing customer services.
“In response to the strong momentum our business has demonstrated over the past several years, we are pleased to announce this new expansion plan,” said Thomas McGrath, vice president of quality and regulatory at LSNE. “With the opening of the new, state-of-the-art laboratory, we will be well positioned to increase our analytical and microbiology capabilities to continue to support our clients and their clinical and commercial products. We have received increased customer demand over the last few years, and with the support of the Permira Funds, we are now able to increase our position as a full-service provider for parenteral products.”